Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Polycystic ovary syndrome is the main cause of hirsutism in premenopausal Iranian women.

Idiopathic chronic telogen effluvium in women causes sudden hair loss without a known cause, often linked to emotional distress.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

Hirsutism involves excessive hair growth due to hormonal issues and can be treated with medication or surgery.

Hirsutism in women is mostly caused by polycystic ovary syndrome and idiopathic hyperandrogenism.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

Finasteride reduces hair growth in women with hirsutism and works better with electrolysis.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

Psychotropic medications can cause skin problems but also treat some skin conditions.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Hirsutism requires identifying the cause to choose the right treatment, which may include medications like oral contraceptives or dexamethasone.

PCOS involves high 11-oxygenated androgens and BPA may worsen it, while IH is not inflammatory.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

Spironolactone treatment reduced hair growth and androgen levels in hirsute women, but the overall effectiveness was just adequate.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

The document concludes that while white skin, nail, and mucosa diseases increase skin cancer risk, they are generally harmless, especially compared to darker pigmentation conditions.

Women with hirsutism have different levels of omentin-1, which may be linked to the condition and its genetic aspects.

The conclusion is that PCOS is a common cause of hirsutism in young obese women, and early treatment is important to reduce the risk of metabolic syndrome.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Idiopathic hirsutism is the most common cause, followed by PCOS, and insulin resistance should be checked in patients with acanthosis nigricans.

Hypothyroidism in dogs is usually caused by immune system issues or gland atrophy, affects middle-aged purebreds most, and is treatable with medication.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

Idiopathic hirsutism is the most common cause of hirsutism in women, followed by PCOS.

Personalized treatment is crucial for women with hyperandrogenism-related acne and hirsutism.

Obesity is strongly linked to the severity of hirsutism in women.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Hyperandrogenism in women often causes acne and excess hair, treatable with personalized plans including weight loss, hair removal, and medications.